COMMUNIQUÉS West-GlobeNewswire

-
MESA LABS DECLARES QUARTERLY DIVIDEND
05/04/2024 -
Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024
04/04/2024 -
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2024
04/04/2024 -
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/04/2024 -
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
04/04/2024 -
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
04/04/2024 -
Werewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual Meeting
04/04/2024 -
Monthly information on share capital and company voting rights
04/04/2024 -
Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders and Genetic Metabolic Dieticians International
04/04/2024 -
Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions
04/04/2024 -
Kno2 Launches New MuleSoft Integration
04/04/2024 -
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
04/04/2024 -
GENFIT : Résultats financiers annuels 2023 et point sur les activités de la Société
04/04/2024 -
Revolution Medicines to Participate in Upcoming Investor Conferences
04/04/2024 -
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
04/04/2024 -
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
04/04/2024 -
RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting
04/04/2024 -
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/04/2024 -
Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment
04/04/2024
Pages